Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

Contrary to Previous Studies, Sex May Not Impact Efficacy of Immunotherapy

January 10th 2019, 7:40pm

Article

A recent meta-analysis has found no noticeable difference in immunotherapy’s efficacy based on patient sex.

Next-Generation Sequencing Continues to Personalize Cancer Care

January 4th 2019, 6:37pm

Article

Next-generation sequencing and personalized approaches will continue to improve cancer outcomes. But there’s still much work to be done.

Immunotherapy in Lung Cancer: 'The Sky Is the Limit'

January 2nd 2019, 10:28pm

Article

An expert discusses the current landscape – as well as future prospects – for immunotherapy in lung cancer.

Billionaire Philanthropist Discusses His Institute's Work to Perfect Cancer Immunotherapy

December 18th 2018, 6:42pm

Article

Immunotherapy has become a buzzword in the cancer community, but to Sean Parker it’s much more. The 39-year-old billionaire is intensely focused on the promise of immunotherapy, and has become a major force in helping to drive its potential to cure cancers.

Immunotherapy Side Effects May Be More Prevalent in Real World Than in Studies

December 3rd 2018, 7:28pm

Article

A retrospective study found that clinical trials may have fewer reported side effects than the real world.

Clinical Trials Play Key Role in Future of Bladder Cancer

November 29th 2018, 7:42pm

Article

While the treatment landscape continues to grow in bladder cancer, researchers should continue to follow the evidence, but accrual of patients in clinical trials is also key, according to Petros Grivas, M.D., Ph.D.

Managing Bladder Cancer in the Era of Cancer Immunotherapy

November 26th 2018, 3:00am

Article

Although immunotherapies show promise for patients, there are still challenges ahead.

Immunotherapy Provides Long-Awaited Progress in Small Cell Lung Cancer

November 6th 2018, 9:00pm

Article

Promising results from a recent trial are laying the groundwork for the first change in frontline small cell lung cancer in two decades.

Patients With High-Risk Non-Muscle Invasive Bladder Cancer Show Response to Keytruda

October 25th 2018, 8:54pm

Article

The immunotherapy agent Keytruda is showing promise for treating non-muscle invasive bladder cancer, according to a recent study.

Cancer Researchers Win Nobel Prize

October 2nd 2018, 12:23am

Article

Immunotherapy pioneers James P. Allison and Dr. Tasuku Honjo have won the 2018 Nobel Prize in Physiology or Medicine for their research that eventually led to the use of immune checkpoint inhibitors to treat cancer.